Related references
Note: Only part of the references are listed.Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants
Raul Bardini Bressan et al.
CELL STEM CELL (2021)
Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma
Kosuke Funato et al.
CELL STEM CELL (2021)
Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation
Smruti K. Patel et al.
NEURO-ONCOLOGY (2020)
Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma
Aaron D. Simpson et al.
BRITISH JOURNAL OF CANCER (2020)
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG
Anatoly Nikolaev et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma
Chibawanye Ene et al.
NEURO-ONCOLOGY (2020)
Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas
L. H. Kasper et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Kyle Wierzbicki et al.
CURRENT ONCOLOGY REPORTS (2020)
Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma
T. A. Kluiver et al.
FRONTIERS IN ONCOLOGY (2020)
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Michael H. Meel et al.
CLINICAL CANCER RESEARCH (2020)
Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib
Zhaohui Wang et al.
MOLECULAR CANCER RESEARCH (2020)
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
Jack Meng-Fen Su et al.
PEDIATRIC BLOOD & CANCER (2020)
Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors
Rianne Haumann et al.
CNS DRUGS (2020)
Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
Henriette Pedersen et al.
CANCERS (2020)
Histone H3.3G34-Mutant Intemeuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C. L. Chen et al.
CELL (2020)
Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
G. Fleischhack et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma
Mwangala Precious Akamandisa et al.
NEURO-ONCOLOGY (2019)
Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
Hiroaki Katagi et al.
CLINICAL CANCER RESEARCH (2019)
Preclinical therapeutic targets in diffuse midline glioma
Michael Hananja Meel et al.
DRUG RESISTANCE UPDATES (2019)
Rapid Generation of Somatic Mouse Mosaics with Locus-Specific, Stably Integrated Transgenic Elements
Gi Bum Kim et al.
CELL (2019)
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
Coralie Werbrouck et al.
CLINICAL CANCER RESEARCH (2019)
Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets
Razina Aziz-Bose et al.
CURRENT OPINION IN ONCOLOGY (2019)
EXTH-60. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
Takahiro Sasaki et al.
NEURO-ONCOLOGY (2019)
PDTM-34. RADIOSENSITIZATION BY BRD4 INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA
Takahiro Sasaki et al.
NEURO-ONCOLOGY (2019)
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
Mahmoud Toulany
GENES (2019)
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model
Nundia Louis et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma
Patrick C. Flannery et al.
ONCOLOGY REPORTS (2018)
Dual HDAC and PI3K Inhibition Abrogates NF kappa B- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal et al.
CANCER RESEARCH (2018)
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
Ziv Versano et al.
Oncotarget (2018)
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]
Guido Frosina et al.
SCIENTIFIC REPORTS (2018)
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Michael H. Meel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies
Eleonore Maury et al.
EPIGENETICS (2017)
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
Dominik Sturm et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases
Zhihong J. Wang et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Francisco J. Cordero et al.
MOLECULAR CANCER RESEARCH (2017)
Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas
Amanda R. King et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
Rintaro Hashizume
NEUROLOGIA MEDICO-CHIRURGICA (2017)
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas
Magimairajan Issai Vanan et al.
NEUROTHERAPEUTICS (2017)
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study
Margaret E. Macy et al.
PEDIATRIC BLOOD & CANCER (2017)
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy
Alice Agliano et al.
ONCOTARGET (2017)
H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas
Manav Pathania et al.
CANCER CELL (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma
Hiroaki Miyahara et al.
CANCER LETTERS (2017)
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas
Trent R. Hummel et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG
David Castel et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
Vladimir Amani et al.
BMC CANCER (2016)
The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
Pamela Viani de Andrade et al.
CANCER CELL INTERNATIONAL (2016)
Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism
Tammy Hennika et al.
JOURNAL OF CHILD NEUROLOGY (2016)
EPT-15A PHASE1/2 CLINICAL TRIAL OF VELIPARIB (ABT-888) AND RADIATION FOLLOWED BY MAINTENANCE THERAPY WITH VELIPARIB AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A PEDIATRIC BRAIN TUMOR CONSORTIUM INTERIM REPORT OF PHASE II STUDY
Patricia Baxter et al.
NEURO-ONCOLOGY (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Carl Koschmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Mutations in chromatin machinery and pediatric high-grade glioma
Rishi R. Lulla et al.
SCIENCE ADVANCES (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition
Isabella C. Taylor et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
Yevgen Chornenkyy et al.
MOLECULAR CANCER THERAPEUTICS (2015)
TR-14 * A FEASIBILITY AND RANDOMIZED PHASE II STUDY OF VORINOSTAT, BEVACIZUMAB, OR TEMOZOLOMIDE DURING RADIATION FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMA: CHILDREN'S ONCOLOGY GROUP STUDY ACNS0822
L. M. Hoffman et al.
NEURO-ONCOLOGY (2015)
Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma
Pawel Buczkowicz et al.
FRONTIERS IN ONCOLOGY (2015)
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019
Donatella Vecchio et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis
Ralph Salloum et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Predictability, efficacy and safety of radiosensitization of glioblastoma- initiating cells by the ATM inhibitor KU-60019
Donatella Vecchio et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center
Francisco Helder Cavalcante Felix et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Maura Massimino et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Targeting Wee1 for the treatment of pediatric high-grade gliomas
Sabine Mueller et al.
NEURO-ONCOLOGY (2014)
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Chris Jones et al.
NATURE REVIEWS CANCER (2014)
Inhibition of Polo-Like Kinase 1 Induces Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Ionizing Radiation
Julia Alejandra Pezuk et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells
Andressa Gois Morales et al.
CHILDS NERVOUS SYSTEM (2013)
Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2013)
Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood: A Children's Oncology Group Phase 2 Study
Kristin A. Bradley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
Viola Caretti et al.
MOLECULAR CANCER THERAPEUTICS (2013)
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
Kelly L. Barton et al.
PLOS ONE (2013)
Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double-Strand Break-Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein
Alessandro Raso et al.
BRAIN PATHOLOGY (2012)
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger et al.
NEURO-ONCOLOGY (2011)
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Ian F. Pollack et al.
NEURO-ONCOLOGY (2011)
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
Dannis G. van Vuurden et al.
ONCOTARGET (2011)
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
J. Russell Geyer et al.
EUROPEAN JOURNAL OF CANCER (2010)
Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
Alberto Broniscer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Brain Tumors Across the Age Spectrum: Biology, Therapy, and Late Effects
Thomas E. Merchant et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade Glioma
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2009)
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A Children's Oncology Group phase I study
Kristin A. Bradley et al.
NEURO-ONCOLOGY (2008)
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report
Ian F. Pollack et al.
NEURO-ONCOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Share Paper
